| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |